Global Feed Anticcocidials Market - 2022-2029

Global Feed Anticcocidials Market - 2022-2029:

Market Overview

Feed Anticoccidials Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 4.89% during the forecast period (2022-2029).

Feed anticoccidials are used to treat coccidials in poultry and other animals and widely used as an additive in feed and veterinary drugs. These are active substances which belong to the group of polyether ionophore antibiotics and are produced by streptomyces albus. The coccidia are responsible for major economic losses of the livestock industry as coccidiosis is an infectious disease of the intestinal tract of wild and domestic animals caused by different protozoa. Some of the control measures include good husbandry as a prime requirement and the use of anticoccidial drugs for prophylaxis and treatment. The protozoan type parasites live and multiply in the intestinal tract and cause tissue damage resulting damage interferes with food digestion and nutrient absorption. For the drug to be effective anticoccidial, it should be used prophylactically instead of therapeutically and the early control measures should be followed for the prevention. Increasing demand for natural feed anticoccidials, due to rising consumer awareness provides a huge market opportunity for the key players operating in the feed anticoccidials market.

Market Dynamics: Rising consumer awareness towards the poultries and other animals

Various changes have been witnessed regarding the consumption patterns and dietary habits of the population due to which there has been a shift towards the increased consumption of poultry. Furthermore, various animal health awareness campaigns are also initiated by the government to spread awareness about the importance of animal health. Feed anticoccidials have witnessed huge attention as it plays a major role in maintaining the gut health and immunity of animals. There is an increase in the demand for natural animal feed additives, which have negligible side effects. This results in the rise in demand majorly among poultry farmers. With this, the rising incidence of chronic diseases associated with the consumption of animal by-products also increases the animal feed anticoccidials market. The dry form is mixed in the feed for animals including poultry and others. Also, the dry form is generally available in almost all the stores, as it is mixed with the feed. It occurs owing to the infestation of coccidia in the intestines. Coccidiosis is still a severe disease in poultry, also having the ability to disrupt the poultry industry economically due to which proper control measures need to be followed for the complete prevention of its occurrence. Usage of anticoccidial drugs for both prophylaxis and treatment and sound husbandry systems are primary requirements to curb coccidiosis in poultry.

Market Segmentation: Oral segment accounted for the highest share in global feed anticoccidials market

In 2021, the oral segment dominated the market, accounting for YY% of global sales as it is widely used in dietary supplements. Due to widespread emergence of antimicrobial resistance, concerns have been raised regarding the safety of anticoccidials and the potential impact on animal resulting in the use of oral drugs. The intestinal damage caused by the disease results in decreased feed intake and retarded growth as well as suppression of cell-mediated immune response and low survival, all of which have significant adverse implications for the commercial poultry. Anticoccidial drugs added to the feed constitute a good preventative measure and are convenient for large-scale use due to which these drugs are widely used to prevent the disease. Scientific evidence has shown that these supplements are used to optimize the health of animals by positive manipulation of the gastrointestinal tract as these drugs are based on the antimicrobial mode of action.

Geographical Penetration: APAC is the dominating region during the forecast period

APAC is projected to be the dominating region due to the enormous presence of domesticated animals in the developing countries such as China, Japan and other countries. Increasing awareness about animal health and growing health expenditure, especially in India and China has driven the demand in this region. China and India also saw significant increases in livestock breeding for meat and poultry products. According to the National Poultry Newspaper, poultry requires 60 percent protein, 13 percent fat and 3 percent calcium, the required nutrient content is met majorly by poultry by-products and fish meal and these byproducts are available as a feed source. The demand has increased from 119,205.21 metric ton in 2018 to 120,884.63 metric ton in 2019 for the poultries. Higher levels of production are associated with the spread of intensive systems in which food conversion ratios are high which has increased the share of Chinas total livestock production. According to Depart of Animal Husbandry and Dairying, contribution from poultry meat sector was contributed to be 75.32% and poultry egg sector contributed to be 24.67% in India. In addition, the annual production of poultry meat was 4.06 metric tons in the year 2018-2019. All these factors have propelled the demand for the market.

Competitive Landscape:

There are several established participants in the industry and local manufacturers; hence, the market is fragmented. Some major key players are Elanco Animal Health, Ceva Animal Health, Zoetis, Phibro Animal Health, Kemin Industries, Merck Animal Health, Virbac SA, Zydus Animal Health, Bioproperties Pty. Ltd., Huvepharma, Qilu Animal Health Products among others. Some of the major key players invested in expanding their business along. For instance, in March 2021, Eloancoanimal health Inc., launched “zoasheild,clinacox, and cosabody are the three major launches of feed anticoccidials in the year 2021. Through these products the company expanded its product portfolio along which is the three antibiotic alternative intestinal integrity products. This portfolio expansion allows Elanco to better serve Raised Without Antibiotics (RWA) customers and provides a broader suite of solutions to both conventional poultry producers and turkey producers looking for coccidiosis control as this disease of the top producers. In 2020, Huvepharma launched “Monimax” which is EU approved coccidiosis control product. The product can be sold across Europe and in countries that require this certificate, including important global markets like Thailand and Turkey.

COVID-19 Impact:

Negative impact on the global feed anticoccidials market

The initial COVID-19 lockdown caused disruptions in the logistics system and affected the supply of poultry feed across the globe. There had been restrictions and shutdown of poultry feed companies across the globe in the initial phase, which in turn resulted in the shortage of feed for livestock farmers. The sales of edible products such as poultry, meat products, and many others were up to the mark as the supply of food products was insufficient as many of the manufacturers have shut operations due to shortage of labors along with the mass production shutdowns and supply chain disruptions. Shutting down of supermarkets and shops due to COVID-19 lockdown restrictions which has significantly impacted the product revenues. Some of the other reasons which led to decrease in sales of feed anticoccidials food during the pandemic are the high dependence on self-made vegetarian food due to the fear of COVID-19 virus and lockdown which forced people not to move out of their houses.

The global feed anticoccidials market report would provide an access to approximately 61 market data tables, 45 figures and 170 pages